Browse by intervention

Lysoveta DHA-LPC: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve in Issue 01. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

Research issue
Issue 01
Data through
2026-08-09
Evidence map version
v1.1.0

How to read this

Phoenix research is longitudinal and observational: we follow real APOE4 carriers over time and compare each member with their own earlier self, with no placebo group, no randomisation, and members choosing their own interventions.

That means these are strong signals pointing at what to test next, not proof of cause. Most nutrition, supplement and lifestyle research you read online has exactly the same design. The difference is that we say so, and we show you the confounders.

Read the full methods and limits

What the Phoenix community is measuring

Browse exact outcomes and interventions. Each result keeps its source, measurement rule and audit record beside the claim.

Lysoveta DHA-LPC evidence dossier

Evidence collected through 2026-08-09.

Most promising

HDL cholesterol

Laboratory HDL cholesterol result · Aim: higher

Lysoveta DHA-LPC

Repeated positive

Two clean curated cases raised HDL cholesterol by 18.7% and 11.5%; external literature does not establish this Lysoveta lipid effect.

Selected member cases

  1. Lysoveta HDL case two · genotype not disclosed · female · age not disclosed

    HDL cholesterol rose 11.5% in a second clean window; paired values and elapsed days were not printed.

    What else changed: no nearby starts were recorded.

    Next study: repeat HDL cholesterol after a dated Lysoveta DHA-LPC window.

  2. Omega Lifter · APOE4/4 · male · age 40-49

    61.5 → 73 mg/dL · +18.7% · 67 days

    What else changed: no nearby starts were recorded.

    Next study: repeat HDL cholesterol after a dated Lysoveta DHA-LPC window.

2 selected member cases · not a response rate

Logged members
2
Members with repeats
2
Observations
2
Measurements
4
Sources and context

Members with a logged Lysoveta start and repeat HDL cholesterol result; visible cases are curated.

  • report-lines-248-343, reviewed by independent verifier

2 selected cases shown with this evidence.

LDL cholesterol

Laboratory LDL cholesterol result · Aim: lower

Lysoveta DHA-LPC

Positive individual result

The Omega Lifter later recorded LDL cholesterol moving from 139 to 93 mg/dL, down 33.1%; elapsed days were not published.

Selected member cases

  1. Omega Lifter · APOE4/4 · male · age 40-49

    LDL cholesterol fell from 139 to 93 mg/dL, down 33.1%; elapsed days were not printed.

    What else changed: no nearby starts were recorded.

    Next study: repeat LDL cholesterol after a dated Lysoveta DHA-LPC window.

1 selected member case · not a response rate

Logged members
1
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Members with a logged Lysoveta start and repeat LDL cholesterol result; the visible case is curated.

  • report-lines-248-343, reviewed by independent verifier

1 selected case shown with this evidence.

What may work against

Homocysteine

Laboratory homocysteine result · Aim: lower

Lysoveta DHA-LPC

Opposite direction

The Omega Lifter's homocysteine moved opposite the goal from 5.9 to 9.4 µmol/L, while remaining described as normal.

Selected member cases

  1. Omega Lifter · APOE4/4 · male · age 40-49

    Homocysteine rose from 5.9 to 9.4 µmol/L; elapsed days were not printed.

    What else changed: no nearby starts were recorded.

    Next study: repeat Homocysteine after a dated Lysoveta DHA-LPC window.

1 selected member case · not a response rate

Logged members
1
Members with repeats
1
Observations
1
Measurements
2
Sources and context

Members with a logged Lysoveta start and repeat homocysteine result; the visible case is curated.

  • report-lines-248-343, reviewed by independent verifier

1 selected case shown with this evidence.

Keep the map

Take every result into your next experiment.

Get the Issue 01 Evidence Map by email. It groups the same evidence by outcome and by intervention, including what worked, what did not, and what Phoenix wants to test next.

Instant PDF · Issue 02 lands in your inbox the day it publishes · No spam

Turn evidence into your next test

Magnesium and homocysteine is 7 members from an answer.

Forty carriers with a dated start and a repeat blood test close it. Creatine, vitamin D3 and B12 sit further back. Your next blood test is somebody else's answer, and theirs is yours.

Take the 7-minute assessment